Rearrangements between the androgen regulated TMPRSS2 gene promoter and the ETS-related ERG gene result in TMPRSS2-ERG fusion transcripts that have been found in approximately half of prostate cancer cases in the Western world [5]. Here, TMPRSS2 is linked to prostate carcinoma.